Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Using simulated scenarios to train front-line staff in the COVID-19 response

Tucked away in an unassuming annexe at the back of the John Radcliffe Hospital you will find a powerhouse at the centre of training NHS staff on the COVID-19 front line. This is OxSTaR (Oxford Simulation, Teaching and Research), the University of Oxford’s state-of-the-art medical simulation, teaching and research facility. This unit, led by Dr Helen Higham, is part of the Nuffield Division of Anaesthetics in the Nuffield Department of Clinical Neurosciences. It embodies the incredible impact that can be achieved when robust research meets clinical practice — and never more so than in a global crisis such as the one in which we now find ourselves.

For 12 years, OxSTaR has been running simulated scenarios — complete with highly realistic functioning models of patients known as manikins — to understand and improve how healthcare professionals work together and interact with their environment and equipment. They have used the insights gained to provide training across Oxford University Hospitals (OUH). Recent weeks have seen them rise to the unique challenge of supporting front-line clinical staff during a pandemic. Helen is full of praise for everyone involved in this effort, particularly the members of her core team: Rosie Warren, Alan Inglis, Russ Sinclair, Charlie McDermott, Wendy Washbourn and Paul Hambidge. This outstanding example of the University and OUH working in partnership has also hinged on the enthusiastic engagement of OxSTaR’s faculty (largely anaesthetics and intensive care consultants and trainees), and support from OUH Infection Prevention and Control team, Corporate Education, the Chief Medical and Nursing Officers and Oxford Medical Imaging.

Read more on the University of Oxford Medium channel

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.